114 related articles for article (PubMed ID: 1406078)
1. Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment.
Wejstål R; Norkrans G; Lenkei R; Weiland O; Schvarcz R; Frydén A
Liver; 1992 Aug; 12(4 Pt 1):161-7. PubMed ID: 1406078
[TBL] [Abstract][Full Text] [Related]
2. T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
Guadagnino V; Caroleo B; Izzi A; De Rosa G; D'Amelio R
Infection; 1995; 23(3):189-90. PubMed ID: 7499011
[No Abstract] [Full Text] [Related]
3. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
[TBL] [Abstract][Full Text] [Related]
4. The relationship between LeY antigen and the therapeutic efficacy of interferon in chronic hepatitis C.
Sata M; Nakano H; Hino T; Kosedo T; Adachi M; Tanikawa K
Arch Virol Suppl; 1993; 8():265-9. PubMed ID: 7903177
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
[TBL] [Abstract][Full Text] [Related]
6. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
Appasamy R; Bryant J; Hassanein T; Van Thiel DH; Whiteside TL
Clin Immunol Immunopathol; 1994 Dec; 73(3):350-7. PubMed ID: 7955564
[TBL] [Abstract][Full Text] [Related]
7. Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
Panasiuk A; Prokopowicz D; Zak J
Hepatogastroenterology; 2004; 51(58):1088-92. PubMed ID: 15239252
[TBL] [Abstract][Full Text] [Related]
8. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
Bresci G; Del Corso L; Romanelli AM; Giuliano G; Pentimone F
J Am Geriatr Soc; 1993 Aug; 41(8):857-62. PubMed ID: 7688007
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis C with recombinant interferon alfa.
Chen YK; Bala K
West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
[No Abstract] [Full Text] [Related]
10. Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study.
Russo-Mancuso G; Di Gregorio F; Passero E; Sciotto A; Mazzarino MC; Malaponte G; Schilirò G
Br J Haematol; 1995 Feb; 89(2):291-8. PubMed ID: 7873379
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.
Wejstål R; Norkrans G; Weiland O; Schvarcz R; Fuchs D; Wachter H; Fryden A; Glaumann H
Clin Exp Immunol; 1992 Mar; 87(3):340-5. PubMed ID: 1544220
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up evaluation in HCV chronic hepatitis treated with alpha-2b interferon. A comparison of two protocols.
Budillon G; Cimino L; Del Vecchio Blanco C; Mazzacca G; Iaquinto G; D'Ascoli B; Lampasi F; Di Sapio M; Mattera D; Sapio D [corrected to Di Sapio M]
Ital J Gastroenterol; 1994; 26(1):16-20. PubMed ID: 8025301
[TBL] [Abstract][Full Text] [Related]
13. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?
Lin R; Schoeman MN; Craig PI; Bilous M; Grierson J; McDonald JA; Batey RG; Farrell GC
Aust N Z J Med; 1991 Jun; 21(3):387-92. PubMed ID: 1953524
[TBL] [Abstract][Full Text] [Related]
14. [Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers].
Tian Y; Qiu ZF; Li TS
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3354-8. PubMed ID: 16409844
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of T-lymphocytes subsets in adult Thais.
Vithayasai V; Sirisanthana T; Sakonwasun C; Suvanpiyasiri C
Asian Pac J Allergy Immunol; 1997 Sep; 15(3):141-6. PubMed ID: 9438546
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric analysis of peripheral T lymphocytes from patients with mycobacterial diseases].
Wada M
Kekkaku; 1992 May; 67(5):393-407. PubMed ID: 1597937
[TBL] [Abstract][Full Text] [Related]
17. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
Métreau JM
Gut; 1993; 34(2 Suppl):S112-3. PubMed ID: 8314474
[TBL] [Abstract][Full Text] [Related]
18. [Influence of interferon-alpha therapy on the count and function of T lymphocytes in children with chronic hepatitis C].
Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Kupś J; Borowska-Rybus B; Sułat-Syncerek D; Grzegorczyk W
Pol Merkur Lekarski; 2001 Oct; 11(64):344-7. PubMed ID: 11770316
[TBL] [Abstract][Full Text] [Related]
19. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
Piazza M; Orlando R; Tosone G; Tiseo D; Conte MC; Minervini F; Santoro G; Scordino F; Vitale D
Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
